Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Pacific Edge Ltd (PEB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011254
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. PEB spans its expertise in molecular oncology, cancer genetics, bioinformatics, clinical research, technology commercialisation, marketing and sales, among others. The company offers diagnostic services through its facilities in New Zealand, Australia and the US, among others. PEB is headquartered in Dunedin, New Zealand.

Pacific Edge Ltd (PEB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pacific Edge Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pacific Edge Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pacific Edge Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pacific Edge Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Pacific Edge Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pacific Edge Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Pacific Edge Biotech Enters Into Licensing Agreement With Oryzon Genomics 10
Equity Offering 11
Pacific Edge Raises USD14.7 Million in Rights Offering of Shares 11
Pacific Edge Completes Rights Issue Of Ordinary Shares For US$13.1 Million 12
Pacific Edge Completes Private Placement Of Ordinary Shares For US$4.4 Million 13
Pacific Edge Ltd – Key Competitors 14
Pacific Edge Ltd – Key Employees 15
Pacific Edge Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 29, 2017: Pacific Edge: FY18 Interim Results 17
May 24, 2017: Pacific Edge: Full Year Results to 31 March 2017 19
Nov 24, 2016: Pacific Edge Interim Results to 30 September 2016 21
May 26, 2016: PEB: Full Year Results to 31 March 2016 23
Corporate Communications 25
Aug 25, 2016: Chris Gallaher Elected as New Chairman for Pacific Edge Board 25
Jun 02, 2016: Pacific Edge Board Changes Announced 26
Apr 05, 2016: Confirmation Of Director Appointment 27
Feb 11, 2016: PEB Advices New Director Appointment and Special Meeting 28
Other Significant Developments 29
Mar 21, 2017: Callaghan Innovation Growth Grant for Pacific Edge 29
Nov 03, 2016: PE Announces User Programme with Singapore General Hospital 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Pacific Edge Ltd, Medical Equipment, Key Facts, 2017 2
Pacific Edge Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Pacific Edge Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pacific Edge Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pacific Edge Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pacific Edge Ltd, Deals By Market, 2011 to YTD 2017 8
Pacific Edge Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pacific Edge Biotech Enters Into Licensing Agreement With Oryzon Genomics 10
Pacific Edge Raises USD14.7 Million in Rights Offering of Shares 11
Pacific Edge Completes Rights Issue Of Ordinary Shares For US$13.1 Million 12
Pacific Edge Completes Private Placement Of Ordinary Shares For US$4.4 Million 13
Pacific Edge Ltd, Key Competitors 14
Pacific Edge Ltd, Key Employees 15
Pacific Edge Ltd, Subsidiaries 16

★海外企業調査レポート[Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boone Electric Cooperative:発電所・企業SWOT分析
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Pyng Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • Premaitha Health Plc (NIPT):企業の財務・戦略的SWOT分析
    Premaitha Health Plc (NIPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Shv Holdings N.V.:企業の戦略・SWOT・財務分析
    Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grupo Farma:企業の戦略的SWOT分析
    Grupo Farma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • National Power Corp:企業の戦略的SWOT分析
    National Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • UNeMed Corp-製薬・医療分野:企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • Exelixis Inc (EXEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabomet …
  • Theraclone Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theraclone Sciences Inc (Theraclone) is a biotech company that develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers development programs on infectious disease which include novel antibodies to fight pandemic and seasonal influenza. It …
  • Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, …
  • Power Finance Corp Ltd (PFC):企業の財務・戦略的SWOT分析
    Power Finance Corp Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kerecis ehf:製品パイプライン分析
    Summary Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura m …
  • Stolt-Nielsen Ltd (SNI):企業の財務・戦略的SWOT分析
    Stolt-Nielsen Ltd (SNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. …
  • Oman Cables Industry SAOG (OCAI):企業の財務・戦略的SWOT分析
    Oman Cables Industry SAOG (OCAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報
    UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report Summary UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oxford Immunotec Ltd:企業の製品パイプライン分析2018
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Nacco Industries Inc:企業の戦略・SWOT・財務情報
    Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆